Skip to main
ZYXI
ZYXI logo

Zynex Inc (ZYXI) Stock Forecast & Price Target

Zynex Inc (ZYXI) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 33%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Zynex Inc. has experienced a notable 16% year-over-year growth in orders for FY2024, reflecting the company's strong market demand for its electrotherapy and pain management products. Management anticipates significant cost savings of approximately $35 million annually starting in the second half of 2025, alongside plans to increase revenue per sales representative to $1 million, which could enhance overall productivity. Moreover, the company's innovative product offerings, particularly the positively evaluated laser-based system, position Zynex as a leader in non-opioid pain management solutions, further solidifying its competitive advantage in the medical device market.

Bears say

Zynex Inc has indicated a significant decline in sales for Q1 2025, projecting revenues of at least $30 million, which represents a 37% year-over-year drop and a 35% sequential decline, coupled with an expected EPS loss. The company's Q4 2024 revenue was reported at $46 million, which was a 3% year-over-year decrease and below projections, highlighting a concerning trend in both device and supply sales. A notable revision of 2025 revenue expectations to $140 million, down from the previously projected $241 million, underscores the financial difficulties and uncertainties surrounding Zynex's operations and future performance.

Zynex Inc (ZYXI) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 33% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Zynex Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Zynex Inc (ZYXI) Forecast

Analysts have given Zynex Inc (ZYXI) a Buy based on their latest research and market trends.

According to 6 analysts, Zynex Inc (ZYXI) has a Buy consensus rating as of Jul 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Zynex Inc (ZYXI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.